Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.41 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.41 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.37 |
| ▸ | MMP1 | P03956 | 1/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
| ▸ | MMP3 | P08254 | 1/20 | 0.36 |
| ▸ | MMP9 | P14780 | 1/20 | 0.36 |
| ▸ | MMP13 | P45452 | 1/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.35 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.35 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | SRC | P12931 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3749621 | 0.96 | TSHR (0.45) | LMNATSHRNFKB1PMP22SLC22A6 | |
| SCHEMBL14935874 | 0.94 | LMNA (0.39) | LMNATSHRPMP22MMP1MMP2 | |
| SCHEMBL27860849 | 0.92 | LMNA (0.42) | LMNATSHRPMP22MMP1MMP2 | |
| SCHEMBL3749627 | 0.90 | MMP1 (0.39) | LMNATSHRSLC22A6MMP1MMP2 | |
| SCHEMBL94758 | 0.88 | MMP1 (0.38) | LMNATSHRMMP1MMP2MMP3 | |
| SCHEMBL17377946 | 0.87 | LMNA (0.38) | LMNATSHRNFKB1PMP22SLC22A6 | |
| Cadaverine Tartrate SCHEMBL6754064 | 0.86 | TSHR (0.40) | LMNATSHRMMP1MMP2MMP3 | |
| Malic Acid SCHEMBL27687431 | 0.86 | SMN1; SMN2 (0.50) | LMNATSHRPMP22MMP1MMP2 | |
| SCHEMBL1168152 | 0.86 | MMP1 (0.42) | TSHRMMP1MMP2MMP3MMP9 | |
| SCHEMBL20590957 | 0.85 | LMNA (0.55) | LMNATSHRPMP22ALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6331206-B1 | DI- OR TRICARBOXYLIC ACID IS BOTH CATALYST AND CROSSLINKING AGENT WITH A POLYSILOXANE TO FORM AN ESTER, COATING FOR A SHAVER; EXHIBITS INSENSITIVITY TO WATER SO THAT STORAGE AND HANDLING CAN TAKE PLACE IN AIR WITHOUT THE PROPERTIES OF THE | U.S. PHILIPS CORPORATION | 2001-12-18 | — | — | US | claimed |
| WO-2024074589-A1 | PLANT-BASED CHEESE OF THE HALF-HARD TYPE | Upfield Europe B.V. (NL) | 2024-04-11 | — | — | WO | disclosed |
| WO-2023052977-A1 | COMPOSITIONS, METHODS AND USES THEREOF | AVACA PHARMA PRIVATE LIMITED (IN) | 2023-04-06 | — | — | WO | disclosed |
| EP-4132506-A1 | CARBOXYLATE LIGAND MODIFIED FERRIC IRON HYDROXIDE COMPOSITIONS FOR USE IN THE TREATMENT OR PREVENTION OF IRON DEFICIENCY ASSOCIATED WITH LIVER DISEASES | Nemysis Limited (IE) | 2023-02-15 | — | — | EP | disclosed |
| US-11206844-B2 | Dry blend for making extended cheese product | Allied Blending & Ingredients Inc. (US) | 2021-12-28 | — | — | US | disclosed |
| US-20210337820-A1 | DRY BLEND FOR MAKING ANALOGUE CHEESE | Allied Blending LP | 2021-11-04 | — | — | US | disclosed |
| WO-2021204705-A1 | CARBOXYLATE LIGAND MODIFIED FERRIC IRON HYDROXIDE COMPOSITIONS FOR USE IN THE TREATMENT OR PREVENTION OF IRON DEFICIENCY ASSOCIATED WITH LIVER DISEASES | NEMYSIS Ltd. (IE) | 2021-10-14 | — | — | WO | disclosed |
| US-11089793-B2 | Dry blend for making analogue cheese | Allied Blending LP (US) | 2021-08-17 | — | — | US | disclosed |
| CN-108064152-B | Antibacterial compositions comprising copper oxo-hydroxide nanoparticles and their use as biocides | 英国研究与创新署 | 2021-07-09 | — | — | CN | disclosed |
| EP-2925152-B1 | IMPROVED DRY BLEND FOR MAKING CHEESE ANALOGUE | ALLIED BLENDING & INGREDIENTS INC (US) | 2021-01-13 | — | — | EP | disclosed |
| WO-2013138728-A1 | IMPROVED DRY BLEND FOR MAKING ANALOGUE CHEESE | ALLIED BLENDING & INGREDIENTS, INC (US) | 2013-09-19 | — | — | WO | disclosed |
| US-20130243926-A1 | DRY BLEND FOR MAKING ANALOGUE CHEESE | ALLIED BLENDING & INGREDIENTS, INC. (US) | 2013-09-19 | — | — | US | disclosed |
| US-20130122177-A1 | DRY BLEND FOR MAKING EXTENDED CHEESE PRODUCT | Allied Blending & Ingredients Inc. (US) | 2013-05-16 | — | — | US | disclosed |
| WO-2013070874-A1 | IMPROVED DRY BLEND FOR MAKING EXTENDED CHEESE PRODUCT | ALLIED BLENDIND & INGREDIENTS INC. (US) | 2013-05-16 | — | — | WO | disclosed |
| US-20110105443-A1 | SALTS OF MEMANTINE AND COX-INHIBITORS AND THEIR CRYSTAL FORM IN THE TREATMENT OF PAIN | LABORATORIES DEL DR. ESTEVE, S.A. (ES) | 2011-05-05 | — | — | US | disclosed |
| EP-2206767-A2 | Solid cleaning compositions | Ecolab INC. (US) | 2010-07-14 | — | — | EP | disclosed |
| EP-2098500-A1 | Salts of menantine and cox-inhibitors and their crystal form in the treatment of pain | Laboratorios Del. Dr. Esteve, S.A. (ES) | 2009-09-09 | — | — | EP | disclosed |
| US-20040247758-A1 | Food product | H. J. HEINZ COMPANY | 2004-12-09 | — | — | US | disclosed |
| CN-1085051-C | Foaming coffee creamer and instant hot cappuccino | KRAFT FOODS INC (US) | 2002-05-22 | — | — | CN | disclosed |
| CN-1164340-A | Foaming coffee creamer and instant hot cappuccino | KRAFT FOODS INC (US) | 1997-11-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110105443-A1 | SALTS OF MEMANTINE AND COX-INHIBITORS AND THEIR CRYSTAL FORM IN THE TREATMENT OF PAIN | OPRK1, GRIN2A, HTR2A | LMNA 1277/4885TSHR 4171/4885NFKB1 1953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.